Search
for
Sort by
Research 91–120 of 509
- Targeted Therapy– and Chemotherapy-Associated Skin Toxicities: Systematic Review and Meta-Analysis
- A Case of Cicatricial Alopecia Associated with Erlotinib
- The pharmacovigilance analysis of adverse events of erlotinib based on the open access FAERS database
- IL-36γ drives skin toxicity induced by EGFR/MEK inhibition and commensal Cutibacterium acnes
- Skin toxicity caused by EGFR antagonists—An autoinflammatory condition triggered by deregulated IL‐1 signaling?
- Demodex mites
- MARIO LACOUTURE: How Do I Treat a Patient with Dermatologic Toxicities to EGFR Inhibitors?
- Follicular and epidermal alterations in patients treated with ZD1839 (Iressa), an inhibitor of the epidermal growth factor receptor
- Prevention and management of dermatological toxicities related to anticancer agents: ESMO Clinical Practice Guidelines☆
- Anti-Acne Agents Attenuate FGFR2 Signal Transduction in Acne
- Spectrum of skin diseases in Yemen (Hajjah and adjacent region)
- Epidemiology of pediatric skin diseases in the mid-western anatolian region of Turkey
- Ectrodactyly, Soft‐Tissue Syndactyly, and Nodulocystic Acne: Coincidence or Association?
- Cutaneous Toxicities of MEK Inhibitor Use in Children: A Comparison of Binimetinib and Selumetinib
- Drug Eruptions
- Common Topical Medications
- Index
- Acne and Systemic Disease
- Adverse Cutaneous Reactions to Antipsychotics
- Cutaneous effects of the most commonly used antidepressant medication, the selective serotonin reuptake inhibitors
- Adverse Cutaneous Reactions to Mood Stabilizers
- Adverse Cutaneous Reactions to Antidepressants
- Folliculotropic mycosis fungoides in a child: a rare case
- Erosive Pustular Dermatosis of the Scalp Due to Afatinib: A Rare Case
- TREATMENT OF ALOPECIA AREATA
- Fatal Toxic Epidermal Necrolysis Associated With Cetuximab in a Patient With Colon Cancer
- Acne in women
- Adverse cutaneous effects of psychotropic medications
- Acne in Dark Skin
- Hypertrichosis of the pinnae in a patient using panitumumab